RETRACTED ARTICLE: miRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting ZEB1

Abstract

Yao R, Zheng H, Wu L, Cai P. OncoTargets and Therapy. 2018;11:8965–8976

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised over alleged image duplication in Figures 2C and 7A with similar images from unrelated articles, specifically:

• Figure 2C, panel SiHa miR-NC appears to have been duplicated with a similar image in Figure 5D from Zhang et al, 2018 (https://doi.org/10.3892/or.2018.6264).

• Figure 7A, panel miR-NC appears to have been duplicated with a similar image in Figure 7A from Wang et al, 2018 (https://doi.org/10.2147/OTT.S183847).

The authors did not respond to our queries and the Editor determined the findings of the study were no longer valid and advised for the article to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Keywords:

• microRNA-641
• target therapy
• zinc finger E-Box binding homeobox 1
• aggressive behaviors

View retraction statement:

miRNA-641 Inhibits the Proliferation, Migration, and Invasion and Induces Apoptosis of Cervical Cancer Cells by Directly Targeting ZEB1 [Retraction]